{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T20:10:04Z","timestamp":1748808604992,"version":"3.41.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Changhua Christian Hospital, Taiwan","award":["112-CCH-IRP-087","112-CCH-IRP-087","112-CCH-IRP-087"],"award-info":[{"award-number":["112-CCH-IRP-087","112-CCH-IRP-087","112-CCH-IRP-087"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14383-7","type":"journal-article","created":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T19:35:22Z","timestamp":1748806522000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of functional antioxidants on the expansion of gamma delta T-cells and their cellular cytotoxicity against bladder cancer cells"],"prefix":"10.1186","volume":"25","author":[{"given":"Yueh","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung-Jen","family":"Shih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Han","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chin-Pao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Hao","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Hsu","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pai-Fu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Chen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping-Hsiao","family":"Shih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,1]]},"reference":[{"key":"14383_CR1","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1001\/jama.2020.17598","volume":"324","author":"AT Lenis","year":"2020","unstructured":"Lenis AT, Lec PM, Chamie K, Mshs MD. Bladder cancer: A review. JAMA. 2020;324:1980\u201391. https:\/\/doi.org\/10.1001\/jama.2020.17598.","journal-title":"JAMA"},{"key":"14383_CR2","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1016\/S0140-6736(22)01188-6","volume":"400","author":"E Comp\u00e9rat","year":"2022","unstructured":"Comp\u00e9rat E, Amin MB, Cathomas R, Choudhury A, De Santis M, Kamat A, Stenzl A, Thoeny HC, Witjes JA. Current best practice for bladder cancer: a narrative review of diagnostics and treatments. Lancet. 2022;400:1712\u201321. https:\/\/doi.org\/10.1016\/S0140-6736(22)01188-6.","journal-title":"Lancet"},{"key":"14383_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s11658-022-00307-x","volume":"27","author":"M Kanmalar","year":"2022","unstructured":"Kanmalar M, Abdul Sani SF, Kamri NINB, Said NABM, Jamil AHBA, Kuppusamy S, Mun KS, Bradley DA. Raman spectroscopy biochemical characterisation of bladder cancer cisplatin resistance regulated by FDFT1: a review. Cell Mol Biol Lett. 2022;27:9. https:\/\/doi.org\/10.1186\/s11658-022-00307-x.","journal-title":"Cell Mol Biol Lett"},{"key":"14383_CR4","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1080\/14712598.2021.1865910","volume":"21","author":"M Maas","year":"2021","unstructured":"Maas M, St\u00fchler V, Walz S, Stenzl A, Bedke J. Enfortumab vedotin - next game-changer in urothelial cancer. Expert Opin Biol Ther. 2021;21:801\u20139. https:\/\/doi.org\/10.1080\/14712598.2021.1865910.","journal-title":"Expert Opin Biol Ther"},{"key":"14383_CR5","doi-asserted-by":"publisher","first-page":"915837","DOI":"10.3389\/fimmu.2022.915837","volume":"13","author":"J Saura-Esteller","year":"2022","unstructured":"Saura-Esteller J, de Jong M, King LA, Ensing E, Winograd B, de Gruijl TD, Parren PWHI, van der Vliet HJ. Gamma delta T-cell based cancer immunotherapy: past-present-future. Front Immunol. 2022;13:915837. https:\/\/doi.org\/10.3389\/fimmu.2022.915837.","journal-title":"Front Immunol"},{"key":"14383_CR6","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00262-016-1943-1","volume":"66","author":"MD Samy","year":"2017","unstructured":"Samy MD, Tong WL, Yavorski JM, Sexton WJ, Blanck G. T cell receptor gene recombinations in human tumor specimen exome files: detection of T cell receptor-beta VDJ recombinations associates with a favorable oncologic outcome for bladder cancer. Cancer Immunol Immunother. 2017;66:403\u201310. https:\/\/doi.org\/10.1007\/s00262-016-1943-1.","journal-title":"Cancer Immunol Immunother"},{"key":"14383_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41590-020-00818-9","volume":"22","author":"V Verma","year":"2021","unstructured":"Verma V, Jafarzadeh N, Boi S, Kundu S, Jiang Z, Fan Y, Lopez J, Nandre R, Zeng P, Alolaqi F, Ahmad S, Gaur P, Barry ST, Valge-Archer VE, Smith PD, Banchereau J, Mkrtichyan M, Youngblood B, Rodriguez PC, Gupta S, Khleif SN. MEK Inhibition reprograms CD8(+) T lymphocytes into memory stem cells with potent antitumor effects. Nat Immunol. 2021;22:53\u201366. https:\/\/doi.org\/10.1038\/s41590-020-00818-9.","journal-title":"Nat Immunol"},{"key":"14383_CR8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/bs.acr.2024.05.003","volume":"162","author":"N Oberholtzer","year":"2024","unstructured":"Oberholtzer N, Mills S, Mehta S, Chakraborty P, Mehrotra S. Role of antioxidants in modulating anti-tumor T cell immune Resposne. Adv Cancer Res. 2024;162:99\u2013124. https:\/\/doi.org\/10.1016\/bs.acr.2024.05.003.","journal-title":"Adv Cancer Res"},{"issue":"23","key":"14383_CR9","doi-asserted-by":"publisher","first-page":"9198","DOI":"10.1074\/jbc.RA118.006753","volume":"294","author":"P Chakraborty","year":"2019","unstructured":"Chakraborty P, Chatterjee S, Kesarwani P, Thyagarajan K, Iamsawat S, Dalheim A, Nguyen H, Selvam SP, Nasarre P, Scurti G, Hardiman G, Maulik N, Ball L, Gangaraju V, Rubinstein MP, Klauber-DeMore N, Hill EG, Ogretmen B, Yu XZ, Nishimura MI, Mehrotra S. Thioredoxin-1 improves the immunometabolic phenotype of antitumor T cells. J Biol Chem. 2019;294(23):9198\u2013212. https:\/\/doi.org\/10.1074\/jbc.RA118.006753.","journal-title":"J Biol Chem"},{"issue":"5","key":"14383_CR10","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1172\/JCI15073","volume":"110","author":"M Li-Weber","year":"2002","unstructured":"Li-Weber M, Weigand MA, Giaisi M, S\u00fcss D, Treiber MK, Baumann S, Ritsou E, Breitkreutz R, Krammer PH. Vitamin E inhibits CD95 ligand expression and protects T cells from activation-induced cell death. J Clin Invest. 2002;110(5):681\u201390. https:\/\/doi.org\/10.1172\/JCI15073.","journal-title":"J Clin Invest"},{"key":"14383_CR11","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.3390\/antiox9111152","volume":"9","author":"A Meryk","year":"2020","unstructured":"Meryk A, Grasse M, Balasco L, Kapferer W, Grubeck-Loebenstein B, Pangrazzi L. Antioxidants N-acetylcysteine and vitamin C improve T cell commitment to memory and long-term maintenance of immunological memory in old mice. Antioxid (Basel). 2020;9:1152. https:\/\/doi.org\/10.3390\/antiox9111152.","journal-title":"Antioxid (Basel)"},{"key":"14383_CR12","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1002\/JLB.1MR1219-245R","volume":"107","author":"C Peters","year":"2020","unstructured":"Peters C, Kouakanou L, Kabelitz D. A comparative view on vitamin C effects on \u03b1\u03b2- versus \u0393\u03b4 T-cell activation and differentiation. J Leukoc Biol. 2020;107:1009\u201322. https:\/\/doi.org\/10.1002\/JLB.1MR1219-245R.","journal-title":"J Leukoc Biol"},{"key":"14383_CR13","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.3389\/fimmu.2019.01307","volume":"10","author":"E Karkeni","year":"2019","unstructured":"Karkeni E, Morin SO, Bou Tayeh B, Goubard A, Josselin E, Castellano R, Fauriat C, Guittard G, Olive D, Nun\u00e8s JA. Vitamin D controls tumor growth and CD8+ T cell infiltration in breast cancer. Front Immunol. 2019;10:1307. https:\/\/doi.org\/10.3389\/fimmu.2019.01307.","journal-title":"Front Immunol"},{"issue":"1","key":"14383_CR14","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1186\/s12964-024-01848-8","volume":"22","author":"W Zhou","year":"2024","unstructured":"Zhou W, Qu M, Yue Y, Zhong Z, Nan K, Sun X, Wu Q, Zhang J, Chen W, Miao C. Acetylcysteine synergizes PD-1 blockers against colorectal cancer progression by promoting TCF1(+)PD1(+)CD8(+) T cell differentiation. Cell Commun Signal. 2024;22(1):503. https:\/\/doi.org\/10.1186\/s12964-024-01848-8.","journal-title":"Cell Commun Signal"},{"key":"14383_CR15","doi-asserted-by":"publisher","first-page":"5221","DOI":"10.21873\/anticanres.14525","volume":"40","author":"Y Pan","year":"2020","unstructured":"Pan Y, Chiu YH, Chiu SC, Cho DY, Lee LM, Wen YC, Whang-Peng J, Hsiao CH, Shih PH. Gamma\/delta T-cells enhance carboplatin-induced cytotoxicity towards advanced bladder cancer cells. Anticancer Res. 2020;40:5221\u20137. https:\/\/doi.org\/10.21873\/anticanres.14525.","journal-title":"Anticancer Res"},{"key":"14383_CR16","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.21873\/anticanres.15829","volume":"42","author":"YC Shen","year":"2022","unstructured":"Shen YC, Shih HJ, Lin CC, Huang SH, Wu SC, Hsiao CH, Chiu SC, Cho DY, Chang CP, Pan Y, Shih PH. Synergistic benefit of adoptive T cells in combination with chemoradiotherapy against metastatic prostate cancer cells. Anticancer Res. 2022;42:3427\u201334. https:\/\/doi.org\/10.21873\/anticanres.15829.","journal-title":"Anticancer Res"},{"key":"14383_CR17","doi-asserted-by":"publisher","unstructured":"M\u00e4rten A, Lilienfeld-Toal Mv, B\u00fcchler MW, Schmidt J. Zoledronic acid has direct antiproliferative and antimetastatic effect on pancreatic carcinoma cells and acts as an antigen for delta2 gamma\/delta T cells. J Immunother. 2007 May-Jun;30(4):370\u20137. https:\/\/doi.org\/10.1097\/CJI.0b013e31802bff16.","DOI":"10.1097\/CJI.0b013e31802bff16"},{"key":"14383_CR18","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","volume":"20","author":"AD Waldman","year":"2020","unstructured":"Waldman AD, Fritz JM, Lenardo MJ. A guide to cancer immunotherapy: from T cell basic science to clinical practice. Nat Rev Immunol. 2020;20:651\u201368. https:\/\/doi.org\/10.1038\/s41577-020-0306-5.","journal-title":"Nat Rev Immunol"},{"key":"14383_CR19","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41577-018-0009-3","volume":"18","author":"P Golstein","year":"2018","unstructured":"Golstein P, Griffiths GM. An early history of T cell-mediated cytotoxicity. Nat Rev Immunol. 2018;18:527\u201335. https:\/\/doi.org\/10.1038\/s41577-018-0009-3.","journal-title":"Nat Rev Immunol"},{"key":"14383_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/bjh.12090","volume":"160","author":"MS Braza","year":"2013","unstructured":"Braza MS, Klein B. Anti-tumour immunotherapy with Vgamma9Vdelta2 T lymphocytes: from the bench to the bedside. Br J Haematol. 2013;160:123\u201332. https:\/\/doi.org\/10.1111\/bjh.12090.","journal-title":"Br J Haematol"},{"key":"14383_CR21","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41568-023-00560-y","volume":"23","author":"G Oliveira","year":"2023","unstructured":"Oliveira G, Wu CJ. Dynamics and specificities of T cells in cancer immunotherapy. Nat Rev Cancer. 2023;23:295\u2013316. https:\/\/doi.org\/10.1038\/s41568-023-00560-y.","journal-title":"Nat Rev Cancer"},{"key":"14383_CR22","doi-asserted-by":"publisher","first-page":"818679","DOI":"10.3389\/fonc.2022.818679","volume":"12","author":"DS Hong","year":"2022","unstructured":"Hong DS, Butler MO, Pachynski RK, Sullivan R, Kebriaei P, Boross-Harmer S, Ghobadi A, Frigault MJ, Dumbrava EE, Sauer A, Brophy F, Navenot JM, Fayngerts S, Wolchinsky Z, Broad R, Batrakou DG, Wang R, Solis LM, Duose DY, Sanderson JP, Gerry AB, Marks D, Bai J, Norry E, Fracasso PM. Phase 1 clinical trial evaluating the safety and anti-tumor activity of ADP-A2M10 SPEAR T-cells in patients with MAGE-A10+ dead and neck, melanoma, or urothelial tumors. Front Oncol. 2022;12:818679. https:\/\/doi.org\/10.3389\/fonc.2022.818679.","journal-title":"Front Oncol"},{"key":"14383_CR23","doi-asserted-by":"publisher","first-page":"3260","DOI":"10.4049\/jimmunol.0903454","volume":"184","author":"M D\u2019Asaro","year":"2010","unstructured":"D\u2019Asaro M, La Mendola C, Di Liberto D, Orlando V, Todaro M, Spina M, Guggino G, Meraviglia S, Caccamo N, Messina A, Salerno A, Di Raimondo F, Vigneri P, Stassi G, Fourni\u00e8 JJ, Dieli F. V gamma 9V delta 2 T lymphocytes efficiently recognize and kill zoledronate-sensitized, imatinib-sensitive, and imatinib-resistant chronic myelogenous leukemia cells. J Immunol. 2010;184:3260\u20138. https:\/\/doi.org\/10.4049\/jimmunol.0903454.","journal-title":"J Immunol"},{"issue":"18","key":"14383_CR24","doi-asserted-by":"publisher","first-page":"e122299","DOI":"10.1172\/jci.insight.122299","volume":"3","author":"K Pilipow","year":"2018","unstructured":"Pilipow K, Scamardella E, Puccio S, Gautam S, De Paoli F, Mazza EM, De Simone G, Polletti S, Buccilli M, Zanon V, Di Lucia P, Iannacone M, Gattinoni L, Lugli E. Antioxidant metabolism regulates CD8 + T memory stem cell formation and antitumor immunity. JCI Insight. 2018;3(18):e122299. https:\/\/doi.org\/10.1172\/jci.insight.122299.","journal-title":"JCI Insight"},{"key":"14383_CR25","doi-asserted-by":"publisher","first-page":"6006","DOI":"10.1158\/0008-5472.CAN-16-0587","volume":"76","author":"MJ Scheffel","year":"2016","unstructured":"Scheffel MJ, Scurti G, Simms P, Garrett-Mayer E, Mehrotra S, Nishimura MI, Voelkel-Johnson C. Efficacy of adoptive T-cell therapy is improved by treatment with the antioxidant N-acetyl cysteine, which limits activation-induced T-cell death. Cancer Res. 2016;76:6006\u201316. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-0587.","journal-title":"Cancer Res"},{"key":"14383_CR26","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00262-018-2120-5","volume":"67","author":"MJ Scheffel","year":"2018","unstructured":"Scheffel MJ, Scurti G, Wyatt MM, Garrett-Mayer E, Paulos CM, Nishimura MI, et al. N-acetyl cysteine protects anti-melanoma cytotoxic T cells from exhaustion induced by rapid expansion via the downmodulation of FoxO1 in an Akt-dependent manner. Cancer Immunol Immunother. 2018;67:691\u2013702. https:\/\/doi.org\/10.1007\/s00262-018-2120-5.","journal-title":"Cancer Immunol Immunother"},{"key":"14383_CR27","doi-asserted-by":"publisher","first-page":"4397","DOI":"10.1074\/jbc.R111.287995","volume":"287","author":"R Banerjee","year":"2012","unstructured":"Banerjee R. Redox outside the box: linking extracellular redox remodeling with intracellular redox metabolism. J Biol Chem. 2012;287:4397\u2013402. https:\/\/doi.org\/10.1074\/jbc.R111.287995.","journal-title":"J Biol Chem"},{"key":"14383_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-022-00902-0","author":"G Morris","year":"2022","unstructured":"Morris G, Gevezova M, Sarafian V, Maes M. Redox regulation of the immune response. Cell Mol Immunol. 2022;19. https:\/\/doi.org\/10.1038\/s41423-022-00902-0.:1079\u2013\u2009101."},{"key":"14383_CR29","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1089\/ars.2018.7716","volume":"32","author":"D Anthony","year":"2020","unstructured":"Anthony D, Papanicolaou A, Wang H, Seow HJ, To EE, Yatmaz S, Anderson GP, Wijburg O, Selemidis S, Vlahos R, Bozinovski S. Excessive reactive oxygen species inhibit IL-17A+ \u0393\u03b4 T cells and innate cellular responses to bacterial lung infection. Antioxid Redox Signal. 2020;32:943\u201356. https:\/\/doi.org\/10.1089\/ars.2018.7716.","journal-title":"Antioxid Redox Signal"},{"key":"14383_CR30","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.3390\/cells11091460","volume":"11","author":"B Bernicke","year":"2022","unstructured":"Bernicke B, Engelbogen N, Klein K, Franzenburg J, Borzikowsky C, Peters C, Janssen O, Junker R, Serrano R, Kabelitz D. Analysis of the seasonal fluctuation of gammadelta T cells and its potential relation with vitamin D(3). Cells. 2022;11:1460. https:\/\/doi.org\/10.3390\/cells11091460.","journal-title":"Cells"},{"key":"14383_CR31","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41423-019-0247-8","volume":"17","author":"L Kouakanou","year":"2020","unstructured":"Kouakanou L, Xu Y, Peters C, He J, Wu Y, Yin Z, Kabelitz D. Vitamin C promotes the proliferation and effector functions of human \u0393\u03b4 T cells. Cell Mol Immunol. 2020;17:462\u201373. https:\/\/doi.org\/10.1038\/s41423-019-0247-8.","journal-title":"Cell Mol Immunol"},{"key":"14383_CR32","doi-asserted-by":"publisher","first-page":"e953410","DOI":"10.4161\/21624011.2014.953410","volume":"3","author":"G Gruenbacher","year":"2014","unstructured":"Gruenbacher G, Nussbaumer O, Gander H, Steiner B, Leonhartsberger N, Thurnher M. Stress-related and homeostatic cytokines regulate V\u03b39V\u03b42 T-cell surveillance of mevalonate metabolism. Oncoimmunology. 2014;3:e953410. https:\/\/doi.org\/10.4161\/21624011.2014.953410.","journal-title":"Oncoimmunology"},{"key":"14383_CR33","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1089\/ars.2012.4988","volume":"19","author":"J Manning","year":"2013","unstructured":"Manning J, Mitchell B, Appadurai DA, Shakya A, Pierce LJ, Wang H, Nganga V, Swanson PC, May JM, Tantin D, Spangrude GJ. Vitamin C promotes maturation of T-cells. Antioxid Redox Signal. 2013;19:2054\u201367. https:\/\/doi.org\/10.1089\/ars.2012.4988.","journal-title":"Antioxid Redox Signal"},{"key":"14383_CR34","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1073\/pnas.1908158117","volume":"117","author":"RA Luchtel","year":"2020","unstructured":"Luchtel RA, Bhagat T, Pradhan K, Jacobs WR Jr, Levine M, Verma A, Shenoy N. High-dose ascorbic acid synergizes with anti-PD1 in a lymphoma mouse model. Proc Natl Acad Sci U S A. 2020;117:1666\u201377. https:\/\/doi.org\/10.1073\/pnas.1908158117.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"14383_CR35","doi-asserted-by":"publisher","first-page":"765906","DOI":"10.3389\/fimmu.2021.765906","volume":"12","author":"L Kouakanou","year":"2021","unstructured":"Kouakanou L, Peters C, Brown CE, Kabelitz D, Wang LD, Vitamin C. From supplement to treatment: a re-emerging adjunct for cancer immunotherapy? Front Immunol. 2021;12:765906. https:\/\/doi.org\/10.3389\/fimmu.2021.765906.","journal-title":"Front Immunol"},{"key":"14383_CR36","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/s1472-9792(03)00002-7","volume":"83","author":"WR Waters","year":"2003","unstructured":"Waters WR, Nonnecke BJ, Foote MR, Maue AC, Rahner TE, Palmer MV, Whipple DL, Horst RL, Estes DM. Mycobacterium bovis Bacille Calmette-Guerin vaccination of cattle: activation of bovine CD4+ and gamma delta TCR+ cells and modulation by 1,25-dihydroxyvitamin D3. Tuberculosis (Edinb). 2003;83:287\u201397. https:\/\/doi.org\/10.1016\/s1472-9792(03)00002-7.","journal-title":"Tuberculosis (Edinb)"},{"issue":"7","key":"14383_CR37","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1016\/j.cell.2025.01.043","volume":"188","author":"X He","year":"2025","unstructured":"He X, Wang Q, Cheng X, Wang W, Li Y, Nan Y, Wu J, Xiu B, Jiang T, Bergholz JS, Gu H, Chen F, Fan G, Sun L, Xie S, Zou J, Lin S, Wei Y, Lee J, Asara JM, Zhang K, Cantley LC, Zhao JJ. Lysine vitcylation is a vitamin C-derived protein modification that enhances STAT1-mediated immune response. Cell. 2025;188(7):1858\u2013e187721. https:\/\/doi.org\/10.1016\/j.cell.2025.01.043.","journal-title":"Cell"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14383-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14383-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14383-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T19:35:23Z","timestamp":1748806523000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14383-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,1]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14383"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14383-7","relation":{"references":[{"id-type":"doi","id":"10.1038\/s41423-022-00902-0","asserted-by":"subject"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,1]]},"assertion":[{"value":"3 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}}],"article-number":"980"}}